Literature DB >> 18773311

Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Daniela L Rebolledo1, Alicia N Minniti, Paula M Grez, Ricardo Fadic, Rebecca Kohn, Nibaldo C Inestrosa.   

Abstract

Inclusion body myositis (IBM) is the most common myopathy in people over 50 years of age. It involves an inflammatory process that, paradoxically, does not respond to anti-inflammatory drugs. A key feature of IBM is the presence of amyloid-beta-peptide aggregates called amyloid deposits, which are also characteristic of Alzheimer's disease. The use of animals that mimic at least some characteristics of a disease has become very important in the quest to elucidate the molecular mechanisms underlying this and other pathogeneses. Although there are some transgenic mouse strains that recreate some aspects of IBM, in this review, we hypothesize that the great degree of similarity between nematode and human genes known to be involved in IBM as well as the considerable conservation of biological mechanisms across species is an important feature that must be taken into consideration when deciding on the use of this nematode as a model. Straightforward laboratory techniques (culture, transformation, gene knockdown, genetic screenings, etc.) as well as anatomical, physiological, and behavioral characteristics add to the value of this model. In the present work, we review evidence that supports the use of Caenorhabditis elegans as a biological model for IBM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773311     DOI: 10.1007/s12035-008-8041-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  219 in total

1.  Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.

Authors:  A Alvarez; C Opazo; R Alarcón; J Garrido; N C Inestrosa
Journal:  J Mol Biol       Date:  1997-09-26       Impact factor: 5.469

2.  Direct observation of stress response in Caenorhabditis elegans using a reporter transgene.

Authors:  C D Link; J R Cypser; C J Johnson; T E Johnson
Journal:  Cell Stress Chaperones       Date:  1999-12       Impact factor: 3.667

3.  On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease.

Authors:  Allen D Roses
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

4.  Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model.

Authors:  Michael C Sugarman; Masashi Kitazawa; Michael Baker; Vincent J Caiozzo; Henry W Querfurth; Frank M LaFerla
Journal:  Neurobiol Aging       Date:  2005-06-13       Impact factor: 4.673

5.  Structure of myosin/paramyosin filaments from a molluscan smooth muscle.

Authors:  L Castellani; P Vibert; C Cohen
Journal:  J Mol Biol       Date:  1983-07-15       Impact factor: 5.469

6.  A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation.

Authors:  G V De Ferrari; M A Canales; I Shin; L M Weiner; I Silman; N C Inestrosa
Journal:  Biochemistry       Date:  2001-09-04       Impact factor: 3.162

Review 7.  Wnt signaling function in Alzheimer's disease.

Authors:  G V De Ferrari; N C Inestrosa
Journal:  Brain Res Brain Res Rev       Date:  2000-08

Review 8.  Role of copper in prion diseases: deleterious or beneficial?

Authors:  Lorena Varela-Nallar; Alfonso González; Nibaldo C Inestrosa
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.

Authors:  T Rees; P I Hammond; H Soreq; S Younkin; S Brimijoin
Journal:  Neurobiol Aging       Date:  2003-10       Impact factor: 4.673

10.  In vivo aggregation of beta-amyloid peptide variants.

Authors:  D S Fay; A Fluet; C J Johnson; C D Link
Journal:  J Neurochem       Date:  1998-10       Impact factor: 5.372

View more
  6 in total

Review 1.  Animal models of inflammatory myopathy.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

2.  The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo.

Authors:  Alicia N Minniti; Macarena S Arrazola; Marcela Bravo-Zehnder; Francisca Ramos; Nibaldo C Inestrosa; Rebeca Aldunate
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

Review 3.  Theories of the pathogenesis of inclusion body myositis.

Authors:  Steven A Greenberg
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.686

4.  Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.

Authors:  Alicia N Minniti; Daniela L Rebolledo; Paula M Grez; Ricardo Fadic; Rebeca Aldunate; Irene Volitakis; Robert A Cherny; Carlos Opazo; Colin Masters; Ashley I Bush; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2009-01-06       Impact factor: 14.195

Review 5.  Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.

Authors:  Steven D Buckingham; Andrew K Jones; Laurence A Brown; David B Sattelle
Journal:  Pharmacol Rev       Date:  2009-03-16       Impact factor: 25.468

6.  A high-fidelity cell lineage tracing method for obtaining systematic spatiotemporal gene expression patterns in Caenorhabditis elegans.

Authors:  Daniel L Mace; Peter Weisdepp; Louis Gevirtzman; Thomas Boyle; Robert H Waterston
Journal:  G3 (Bethesda)       Date:  2013-05-20       Impact factor: 3.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.